Evidence map›Paper›PMID 33280045›Full record

ReviewThe Journal of antimicrobial chemotherapy2020

White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks.

Fabiana Arieti, Siri Göpel, Marcella Sibani, Elena Carrara, Maria Diletta Pezzani, Rita Murri, Nico T Mutters, Lorena Lòpez-Cerero, Andreas Voss, Roberto Cauda and 2 more

Abstract readReviewConsensus Statement
In one paragraph

Review in The Journal of antimicrobial chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fabiana ArietiInfectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Siri GöpelInfectious Diseases, Department of Internal Medicine I, Tübingen University Hospital, Tübingen, Germany.
Marcella SibaniInfectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Elena CarraraInfectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Maria Diletta PezzaniInfectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Rita MurriInstitute of Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Universitá Cattolica del Sacro Cuore, Rome, Italy.
Nico T MuttersInstitute of Hygiene and Public Health, Bonn University Hospital, Bonn, Germany.
Lorena Lòpez-CereroMicrobiology and Infectious Diseases Unit, University Hospital Virgen Macarena, Sevilla, Spain.
Andreas VossDepartment of Clinical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Roberto CaudaInstitute of Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Universitá Cattolica del Sacro Cuore, Rome, Italy.
Evelina TacconelliInfectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
ARCH working group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe outpatient setting is a key scenario for the implementation of antimicrobial stewardship (AMS) activities, considering that overconsumption of antibiotics occurs mainly outside hospitals. This publication is the result of a joint initiative by the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks, which is aimed at formulating a set of target actions for linking surveillance data with AMS activities in the outpatient setting.

methodsA scoping review of the literature was carried out in three research areas: AMS leadership and accountability; antimicrobial usage and AMS; antimicrobial resistance and AMS. Consensus on the actions was reached through a RAND-modified Delphi process involving over 40 experts in infectious diseases, clinical microbiology, AMS, veterinary medicine or public health, from 18 low-, middle- and high-income countries.

resultsEvidence was retrieved from 38 documents, and an initial 25 target actions were proposed, differentiating between essential or desirable targets according to clinical relevance, feasibility and applicability to settings and resources. In the first consultation round, preliminary agreement was reached for all targets. Further to a second review, 6 statements were re-considered and 3 were deleted, leading to a final list of 22 target actions in the form of a practical checklist.

conclusionsThis White Paper is a pragmatic and flexible tool to guide the development of calibrated surveillance-based AMS interventions specific to the outpatient setting, which is characterized by substantial inter- and intra-country variability in the organization of healthcare structures, maintaining a global perspective and taking into account the feasibility of the target actions in low-resource settings.

Indexed as

Antimicrobial StewardshipAnti-Bacterial AgentsHospitalsHumansMagnetsOutpatientsAnti-Bacterial Agents

Identifiers

PMID33280045
PMCPMC7719405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.